Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of Quantitative Flow Ratio-Derived Virtual Angioplasty with Post-Angioplasty Fractional Flow Reserve-The QIMERA-I Study.
Amat-Santos IJ, Marengo G, Sánchez-Luna JP, Cortés Villar C, Rivero Crespo F, Jiménez Díaz VA, de la Torre Hernández JM, Pérez de Prado A, Sabaté M, López-Palop R, Vegas Valle JM, Suárez de Lezo J, Fernandez Cordon C, Gonzalez JC, García-Gómez M, Redondo A, Carrasco Moraleja M, San Román JA. Amat-Santos IJ, et al. Among authors: de la torre hernandez jm. J Cardiovasc Dev Dis. 2023 Dec 31;11(1):14. doi: 10.3390/jcdd11010014. J Cardiovasc Dev Dis. 2023. PMID: 38248884 Free PMC article.
Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2).
de la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, Pérez de Prado A, Rivero F, Sanchis J, Larman M, Diaz JF, Elizaga J, Moreiras JM, Gomez Jaume A, Hernández JM, Mauri J, Recalde AS, Bullones JA, Rumoroso JR, Del Blanco BG, Baz JA, Bosa F, Botas J, Hernández F; ESTROFA-2 Study Group. de la Torre Hernández JM, et al. Among authors: hernandez f, hernandez jm. JACC Cardiovasc Interv. 2010 Sep;3(9):911-9. doi: 10.1016/j.jcin.2010.06.010. JACC Cardiovasc Interv. 2010. PMID: 20850089 Free article.
Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study.
de la Torre Hernandez JM, Hernández Hernandez F, Alfonso F, Rumoroso JR, Lopez-Palop R, Sadaba M, Carrillo P, Rondan J, Lozano I, Ruiz Nodar JM, Baz JA, Fernandez Nofrerias E, Pajin F, Garcia Camarero T, Gutierrez H; LITRO Study Group (Spanish Working Group on Interventional Cardiology). de la Torre Hernandez JM, et al. Among authors: hernandez hernandez f. J Am Coll Cardiol. 2011 Jul 19;58(4):351-8. doi: 10.1016/j.jacc.2011.02.064. J Am Coll Cardiol. 2011. PMID: 21757111 Free article. Clinical Trial.
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).
De la Torre Hernandez JM, Alfonso F, Sanchez Recalde A, Jimenez Navarro MF, Perez de Prado A, Hernandez F, Abdul-Jawad Altisent O, Roura G, Garcia Camarero T, Elizaga J, Rivero F, Gimeno F, Calviño R, Moreu J, Bosa F, Rumoroso JR, Bullones JA, Gallardo A, Fernandez Diaz JA, Ruiz Arroyo JR, Aragon V, Masotti M; ESTROFA-LM Study Group. De la Torre Hernandez JM, et al. Among authors: hernandez f. Am J Cardiol. 2013 Mar 1;111(5):676-83. doi: 10.1016/j.amjcard.2012.11.019. Epub 2012 Dec 27. Am J Cardiol. 2013. PMID: 23273715 Clinical Trial.
Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach.
de la Torre Hernandez JM, Lopez-Palop R, Garcia Camarero T, Carrillo Saez P, Martin Gorria G, Frutos Garcia A, Arnaez Corada B, Cordero Fort A, Gomez Delgado JM, Agudo Quilez P, Lee DH, Rodriguez IM, Sainz Laso F, Khashaba A, Miralles Arques S, Zueco Gil J. de la Torre Hernandez JM, et al. EuroIntervention. 2013 Nov;9(7):824-30. doi: 10.4244/EIJV9I7A136. EuroIntervention. 2013. PMID: 23685248 Free article.
A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).
de Belder A, de la Torre Hernandez JM, Lopez-Palop R, O'Kane P, Hernandez Hernandez F, Strange J, Gimeno F, Cotton J, Diaz Fernandez JF, Carrillo Saez P, Thomas M, Pinar E, Curzen N, Baz JA, Cooter N, Lozano I, Skipper N, Robinson D, Hildick-Smith D; XIMA Investigators. de Belder A, et al. Among authors: de la torre hernandez jm, hernandez hernandez f. J Am Coll Cardiol. 2014 Apr 15;63(14):1371-5. doi: 10.1016/j.jacc.2013.10.053. Epub 2013 Nov 21. J Am Coll Cardiol. 2014. PMID: 24216285 Free article. Clinical Trial.
Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries.
de la Torre Hernandez JM, Baz Alonso JA, Gómez Hospital JA, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, Roura Ferrer G, Recalde AS, Martínez-Luengas IL, Gomez Lara J, Hernandez Hernandez F, Pérez-Vizcayno MJ, Cequier Fillat A, Perez de Prado A, Gonzalez-Trevilla AA, Jimenez Navarro MF, Mauri Ferre J, Fernandez Diaz JA, Pinar Bermudez E, Zueco Gil J; IVUS-TRONCO-ICP Spanish study. de la Torre Hernandez JM, et al. Among authors: hernandez hernandez f. JACC Cardiovasc Interv. 2014 Mar;7(3):244-54. doi: 10.1016/j.jcin.2013.09.014. JACC Cardiovasc Interv. 2014. PMID: 24650399 Free article.
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.
Valgimigli M, Sabaté M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Ferrante G. Valgimigli M, et al. Among authors: de la torre hernandez jm, de belder a. BMJ. 2014 Nov 4;349:g6427. doi: 10.1136/bmj.g6427. BMJ. 2014. PMID: 25378023 Free PMC article.
Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2.
de la Torre Hernández JM, Oteo Domínguez JF, Hernández F, García Camarero T, Abdul-Jawad Altisent O, Rivero Crespo F, Cascón JD, Zavala G, Gimeno F, Arrebola Moreno AL, Andraka L, Gómez Menchero A, Bosa F, Carrillo X, Sánchez Recalde Á, Alfonso F, Pérez de Prado A, López Palop R, Sanchis J, Diarte de Miguel JA, Jiménez Navarro M, Muñoz L, Ramírez Moreno A, Tizón Marcos H; ESTROFA-DAPT and ESTROFA-2 study groups. de la Torre Hernández JM, et al. Among authors: hernandez f. Rev Esp Cardiol (Engl Ed). 2015 Oct;68(10):838-45. doi: 10.1016/j.rec.2015.01.008. Epub 2015 Jun 11. Rev Esp Cardiol (Engl Ed). 2015. PMID: 26072146
The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study.
Martin-Reyes R, de la Torre Hernandez JM, Franco-Pelaez J, Lopez-Palop R, Telleria Arrieta M, Amat Santos IJ, Carrillo Saez P, Sanchez-Recalde A, Sanmartin Pena JC, Garcia Camarero T, Brugaletta S, Gimeno de Carlos F, Pinero A, Sorto Sanchez DC, Frutos A, Lasa Larraya G, Navarro F, Farre J. Martin-Reyes R, et al. Among authors: de la torre hernandez jm. Catheter Cardiovasc Interv. 2016 Feb 1;87(2):262-9. doi: 10.1002/ccd.25983. Epub 2015 Jul 25. Catheter Cardiovasc Interv. 2016. PMID: 26213338
199 results